Although there is no cure for COPD yet, there are several approved treatments that can help manage the disease and ease symptoms. Learn more about some of the specific therapies used to treat this ...

Chronic obstructive pulmonary disease causes several symptoms that make breathing difficult, including persistent cough with mucus.

Nuvaira's Lung Denervation System, which is undergoing testing for its use in treating COPD, has been designated a breakthrough device by the U.S. FDA.

DirectRx pharmacy was added to the network of pharmacies distributing newly approved COPD therapy Ohtuvayre (ensifentrine) in the U.S.

Respiratory specialist Noah Greenspan, with his colleagues, talks the ins and outs of supplemental oxygen use for COPD, PH, and PF patients.

While the risk of COPD was highest among traditional cigarette smokers and dual users, e-cigarette users also had a significantly increased risk of COPD over people who’d never used e-cigarettes or ...

Ensifentrine safely and effectively improved lung function and reduced the rate and risk of exacerbations in COPD patients in a trial.

AlphaID, a cheek swab test that can help identify patients with chronic obstructive pulmonary disease (COPD) who have the disease due to alpha-1 antitrypsin deficiency (AATD), is now available for use ...

COPD patients who also have gastroesophageal reflux disease (GERD), known as acid reflux, have a higher risk of acute exacerbations, a review suggests.

Recently published results of a Phase 3 trial show that treating COPD patients with Trelegy Ellipta reduced disease exacerbations and improved lung function and quality of life.

Dosing with ensifentrine, a nebulized inhalation therapy, has begun in a Phase 3 trial in China in adults with moderate-to-severe COPD.

Columnist Caroline Gainer explains how she uses large oxygen concentrators and portable ones to meet her long-term supplemental oxygen needs.